2006
DOI: 10.1017/s104161020625347x
|View full text |Cite
|
Sign up to set email alerts
|

Observations from a 14-week open-label trial with memantine suggest variable response on behavioral symptoms and cognition, depending on former treatment of AD

Abstract: Diagnosis of Asperger Syndrome in a 66-year-old male presenting with depression Asperger Syndrome (AS) is an uncommon condition which is a part of the autistic spectrum disorders group. This condition, first described in 1944 by Hans Asperger was characterized by problems in social integration, verbal communication, empathy and preoccupation with unusual interests (Fitzgerald and Corvin, 2001). Several diagnostic criteria are currently used to diagnose AS, including the ICD-10 (World Health Organization, 1992)… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2006
2006
2009
2009

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…A study comparing the response of patients grouped according to therapies received prior to memantine found that it affected the response to memantine treatment. 30 van Dyck also pointed out that it is important to incorporate nonparametric analyses into the study design as a contingency plan. Finally, bias may be introduced utilizing the last observation carried forward (LOCF) method due to the significant results observed at weeks 12 and 18 but not at 24.…”
Section: Memantine In Moderate To Severe Admentioning
confidence: 99%
“…A study comparing the response of patients grouped according to therapies received prior to memantine found that it affected the response to memantine treatment. 30 van Dyck also pointed out that it is important to incorporate nonparametric analyses into the study design as a contingency plan. Finally, bias may be introduced utilizing the last observation carried forward (LOCF) method due to the significant results observed at weeks 12 and 18 but not at 24.…”
Section: Memantine In Moderate To Severe Admentioning
confidence: 99%